Allopurinol Structural Formula (Image 1)
Allopurinol
Product Images NDC 53002-4821
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 53002-4821). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Allopurinol Is A Structural Analogue Of The Natural Purine Base, Hypoxanthine. It Is An Inhibitor Of Xanthine Oxidase, The Enzyme Responsible For The Conversion Of Hypoxanthine To Xanthine And Of Xanthine To Uric Acid, The End Product Of Purine Metabolism In Man. Allopurinol Is Metabolized To The Corresponding Xanthine Analogue, Oxipurinol (alloxanthine), Which Also Is An Inhibitor Of Xanthine Oxidase. (Image 2)
This text appears to be a list of chemical compounds and their corresponding structural formulas. Namely, the compounds listed are Allopurinol, Oxipurinol, Xanthine, Uric Acid, Hypoxanthine, and purine. Therefore, it is a technical description of chemicals and their structures.*
Label Image (Lbl530024821)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
